Intellipharmaceutics (IPCI) Reports FDA Acceptance for Filing of NDA for Rexista

February 2, 2017 5:21 PM
Intellipharmaceutics International Inc. (Nasdaq: IPCI) today announced that the U.S. Food and Drug Administration ("FDA") has accepted for filing the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments Momentum Movers

Next Articles